Have your own idea? Try our Stock Screener
Belgian (BEL20) Healthcare Sector Analysis
UpdatedFeb 15, 2026
DataAggregated Company Financials
Companies11
- 7D4.5%
- 3M6.4%
- 1Y35.8%
- YTD9.0%
The Healthcare industry is up 4.5% in the last week, with UCB up 6.7%. In the last 12 months, the industry was up 36%. Looking forward, earnings are forecast to grow by 21% annually.
Sector Valuation and Performance
Has the Belgian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 15 Feb 2026 | €109.9b | €12.7b | €2.6b | 30.1x | 41.9x | 8.7x |
| Tue, 13 Jan 2026 | €101.7b | €12.7b | €2.6b | 27.5x | 38.6x | 8x |
| Thu, 11 Dec 2025 | €105.2b | €12.7b | €2.6b | 27x | 39.9x | 8.3x |
| Sat, 08 Nov 2025 | €99.3b | €12.7b | €2.7b | 25.3x | 37.3x | 7.8x |
| Mon, 06 Oct 2025 | €102.0b | €12.2b | €2.4b | 27.9x | 42x | 8.4x |
| Wed, 03 Sep 2025 | €84.4b | €12.2b | €2.4b | 31x | 34.6x | 6.9x |
| Fri, 01 Aug 2025 | €82.0b | €11.0b | €2.0b | 37.4x | 41.8x | 7.4x |
| Sun, 29 Jun 2025 | €70.5b | €11.0b | €1.9b | 34.3x | 36.3x | 6.4x |
| Tue, 27 May 2025 | €70.0b | €11.0b | €2.0b | 33.3x | 35.6x | 6.3x |
| Thu, 24 Apr 2025 | €67.7b | €10.7b | €1.8b | 39.7x | 38x | 6.3x |
| Sat, 22 Mar 2025 | €77.5b | €10.8b | €1.9b | 42.6x | 40.6x | 7.2x |
| Mon, 17 Feb 2025 | €80.3b | €9.7b | €270.4m | 62.1x | 297x | 8.2x |
| Wed, 15 Jan 2025 | €84.2b | €9.8b | €269.7m | 60.9x | 312.2x | 8.6x |
| Fri, 13 Dec 2024 | €78.1b | €9.7b | €270.4m | 59.2x | 288.8x | 8x |
| Sun, 10 Nov 2024 | €77.1b | €9.7b | €272.2m | 61.5x | 283.4x | 7.9x |
| Tue, 08 Oct 2024 | €68.3b | €9.4b | €131.2m | 57.9x | 520.4x | 7.2x |
| Thu, 05 Sep 2024 | €67.4b | €9.4b | €96.2m | 51.9x | 700.5x | 7.2x |
| Sat, 03 Aug 2024 | €64.3b | €9.4b | €59.7m | 60x | 1077.6x | 6.8x |
| Mon, 01 Jul 2024 | €57.9b | €8.9b | €34.3m | 52.6x | 1686.8x | 6.5x |
| Wed, 29 May 2024 | €51.4b | €8.9b | €38.3m | 49.7x | 1340.3x | 5.8x |
| Fri, 26 Apr 2024 | €51.1b | €8.8b | €60.2m | 46.9x | 848.8x | 5.8x |
| Sun, 24 Mar 2024 | €50.5b | €8.7b | €29.6m | 47.2x | 1704.1x | 5.8x |
| Tue, 20 Feb 2024 | €46.2b | €9.1b | -€83,947,978.90 | 41x | -549.9x | 5.1x |
| Thu, 18 Jan 2024 | €41.8b | €9.1b | -€126,007,216.00 | 38.5x | -331.4x | 4.6x |
| Sat, 16 Dec 2023 | €44.3b | €9.1b | -€125,684,761.00 | 35.6x | -352.5x | 4.9x |
| Mon, 13 Nov 2023 | €44.5b | €9.2b | -€145,083,641.00 | 30.5x | -306.9x | 4.9x |
| Wed, 11 Oct 2023 | €48.4b | €9.0b | -€302,095,929.00 | 34.7x | -160.2x | 5.4x |
| Fri, 08 Sep 2023 | €49.6b | €9.0b | -€359,300,450.00 | 34.9x | -138.1x | 5.5x |
| Sun, 06 Aug 2023 | €47.4b | €9.0b | -€328,411,839.00 | 40.6x | -144.4x | 5.3x |
| Tue, 04 Jul 2023 | €40.5b | €9.1b | -€349,817,724.00 | 36.3x | -115.8x | 4.4x |
| Thu, 01 Jun 2023 | €42.0b | €9.1b | -€362,613,373.00 | 37.1x | -115.8x | 4.6x |
| Sat, 29 Apr 2023 | €41.9b | €8.9b | -€263,651,665.00 | 27.9x | -159x | 4.7x |
| Mon, 27 Mar 2023 | €39.8b | €8.9b | -€286,128,158.00 | 25.7x | -139.2x | 4.5x |
| Wed, 22 Feb 2023 | €40.6b | €9.1b | €137.6m | 16.1x | 295.4x | 4.5x |
Price to Earnings Ratio
295.4x
Current Industry PE
- Investors are pessimistic on the Belgian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 42.0x which is lower than its 3-year average PE of 199x.
- The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 8.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 165% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare sector?
| BE Market | 2.54% | |
| Healthcare | 4.54% | |
| Pharma | 6.52% | |
| Healthtech | 3.16% | |
| Healthcare Services | 2.25% | |
| Biotech | 1.91% | |
| Medical Equipment | 0.29% | |
| Life Sciences | 0% | 0 |
Industry PE
- Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 60.1x.
- Analysts are expecting annual earnings growth of 19.6%, which is lower than the prior year's growth of 229.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 97% over the next 5 years.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| UCB UCB | €279.50 | 6.7% +€3.3b | 54.9% | PE39.9x | |
| ARGX argenx | €708.80 | 1.9% +€807.8m | 16.6% | PE33.6x | |
| TUB Financière de Tubize | €238.00 | 5.8% +€578.7m | 62.3% | PE114.2x | |
| FAGR Fagron | €22.75 | 2.2% +€36.6m | 14.2% | PE18.3x | |
| HYL Hyloris Pharmaceuticals | €7.70 | 4.1% +€8.4m | 46.4% | PS25.5x |
